Thompson Investment Management’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.98M Buy
445,441
+130,855
+42% +$3.41M 1.15% 30
2026
Q1
$8.61M Buy
314,586
+98,432
+46% +$3.49M 1.11% 28
2025
Q4
$8.99M Buy
216,154
+58,251
+37% +$2.36M 1.13% 29
2025
Q3
$7.29M Buy
157,903
+6,716
+4% +$358K 0.97% 38
2025
Q2
$7.99M Buy
151,187
+8,644
+6% +$457K 1.13% 31
2025
Q1
$7.93M Buy
142,543
+2,132
+2% +$102K 1.19% 30
2024
Q4
$6.08M Buy
140,411
+129,876
+1,233% +$5.78M 0.87% 45
2024
Q3
$540K Buy
10,535
+1,115
+12% +$74.6K 0.08% 125
2024
Q2
$596K Buy
9,420
+3,150
+50% +$189K 0.09% 113
2024
Q1
$415K Buy
+6,270
New +$509K 0.06% 138

Other funds holding CNXC

Thompson Investment Management's CNXC Position: Q2 2026 in Review

Thompson Investment Management increased its Concentrix (CNXC) stake by 42% in Q2 2026, buying an estimated $3.41M and bringing the position to 445,441 shares worth $9.98M. The position accounts for 1.15% of the portfolio, ranked #30.

Thompson Investment Management first reported a position in CNXC in Q1 2024 and has held it in 10 quarters since. 271 funds tracked by Wall St. Rank hold CNXC as of Q2 2026.

  • Thompson Investment Management held 445,441 shares of Concentrix worth $9.98M as of Q2 2026.
  • Thompson Investment Management bought 130,855 Concentrix shares in Q2 2026, an estimated $3.41M.
  • Concentrix made up 1.15% of Thompson Investment Management's portfolio in Q2 2026, its #30 holding.
  • Thompson Investment Management first reported a position in Concentrix in Q1 2024 and has held it in 10 quarters since.
  • 271 funds tracked by Wall St. Rank held Concentrix as of Q2 2026.

Based on Thompson Investment Management's 13F filing for Q2 2026, filed 13 Jul 2026.